Cell Banking Outsourcing Market Size- By Type, By Cell Type, By Phase- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Cell Banking Outsourcing Market Introduction and Overview

According to SPER Market Research, ' Cell Banking Outsourcing Market Size- By Type, By Cell Type, By Phase- Regional Outlook, Competitive Strategies and Segment Forecast to 2033'state that the Cell Banking Outsourcing Market is predicted to reach USD 56.71 billion by 2033 with a CAGR of 16.5%.

The surging demand for stem cell therapies is a major catalyst for market growth. Stem cell applications in areas like cell therapy, regenerative medicine, drug discovery, toxicity evaluation, and developmental biology research show immense potential in preserving their inherent properties, preventing contamination, and ensuring effective utilization in both foundational and future therapeutic research. Additionally, several stem cells originate from unique sources, such as cord blood previously discarded but now valuable in treating conditions like blood cancers.

Furthermore, the industry for cell banking outsourcing has been affected by the COVID-19 epidemic in both positive and negative ways. Positively, the epidemic has brought attention to how crucial it is to create vaccines and cell-based therapeutics. As a result, the market is expanding faster and there is now a greater need for cell banking services. But the pandemic has also slowed down R&D efforts and upset international supply chains, which has had an impact on the market's overall growth to some degree.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Type, By Cell Type, By Phase

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Charles River Laboratories, Inc., Clean Biologics, Cordlife Group Limited, Cryo-Cell International Inc., Lonza, Merck KGaA, Reliance Life Sciences, SGS Life Sciences, Texcell, Wuxi Apptec, Others

Cell Banking Outsourcing Market Segmentation:

By Type: Based on the Type, Cell Banking Outsourcing Market is segmented as; Master Cell Banking, Viral Cell Banking, Working Cell Banking.

By Cell Type: Based on the Cell Type, Global Cell Banking Outsourcing Market is segmented as; Stem Cell (Adult Stem Cell Banking, Cord Cell Banking, Dental Stem Cell Banking, Embryonic Stem Cell Banking, IPS Stem Cell Banking), Non-stem Cell.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: HLCA2367

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Cell Banking Outsourcing Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Cell Banking Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell Banking Outsourcing Market

7. Global Cell Banking Outsourcing Market, By Type (USD Million)

7.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Type, 2023-2033
7.2. Master Cell Banking
7.3. Viral Cell Banking
7.4. Working Cell Banking

8. Global Cell Banking Outsourcing Market, By Cell Type (USD Million)

8.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Cell Type, 2023-2033
8.2. Stem Cell
- 8.2.1. Adult Stem Cell Banking
- 8.2.2. Cord Cell Banking
- 8.2.3. Dental Stem Cell Banking
- 8.2.4. Embryonic Stem Cell Banking
- 8.2.5. IPS Stem Cell Banking
8.3. Non-stem Cell

9. Global Cell Banking Outsourcing Market, By Phase (USD Million)

9.1. Global Cell Banking Outsourcing Market Value Share and Forecast, By Phase, 2023-2033
9.2. Bank Characterization & Testing
- 9.2.1. Gene Expression Testing
- 9.2.2. Gene Sequencing Testing
- 9.2.3. Karyology Testing
- 9.2.4. Safety Testing
9.3. Bank Preparation
- 9.3.1. Master Cell Bank Preparation
- 9.3.2. Working Cell Bank Preparation
9.4. Bank Storage
- 9.4.1. Cell Storage Stability Testing
- 9.4.2. Master Cell Bank Storage
- 9.4.3. Working Cell Bank Storage

10. Global Cell Banking Outsourcing Market Forecast, 2019-2033 (USD Million)

10.1. Global Cell Banking Outsourcing Market Size and Market Share

11. Global Cell Banking Outsourcing Market, By Type, 2019-2033 (USD Million)

11.1. Global Cell Banking Outsourcing Market Size and Market Share By Type (2019-2026)
11.2. Global Cell Banking Outsourcing Market Size and Market Share By Type (2027-2033)

12. Global Cell Banking Outsourcing Market, By Cell Type, 2019-2033 (USD Million)

12.1. Global Cell Banking Outsourcing Market Size and Market Share By Cell Type (2019-2026)
12.2. Global Cell Banking Outsourcing Market Size and Market Share By Cell Type (2027-2033)

13. Global Cell Banking Outsourcing Market, By Phase, 2019-2033 (USD Million)

13.1. Global Cell Banking Outsourcing Market Size and Market Share By Phase (2019-2026)
13.2. Global Cell Banking Outsourcing Market Size and Market Share By Phase (2027-2033)

14. Global Cell Banking Outsourcing Market, By Region, 2019-2033 (USD Million)

14.1. Global Cell Banking Outsourcing Market Size and Market Share By Region (2019-2026)
14.2. Global Cell Banking Outsourcing Market Size and Market Share By Region (2027-2033)
14.3. Asia-Pacific
- 14.3.1. Australia
- 14.3.2. China
- 14.3.3. India
- 14.3.4. Japan
- 14.3.5. South Korea
- 14.3.6. Rest of Asia-Pacific
14.4. Europe
- 14.4.1. France
- 14.4.2. Germany
- 14.4.3. Italy
- 14.4.4. Spain
- 14.4.5. United Kingdom
- 14.4.6. Rest of Europe
14.5. Middle East and Africa
- 14.5.1. Kingdom of Saudi Arabia
- 14.5.2. United Arab Emirates
- 14.5.3. Rest of Middle East & Africa
14.6. North America
- 14.6.1. Canada
- 14.6.2. Mexico
- 14.6.3. United States
14.7. Latin America
- 14.7.1. Argentina
- 14.7.2. Brazil
- 14.7.3. Rest of Latin America

15. Company Profile

15.1. Charles River Laboratories, Inc.
- 15.1.1. Company details
- 15.1.2. Financial outlook
- 15.1.3. Product summary
- 15.1.4. Recent developments
15.2. Clean Biologics
- 15.2.1. Company details
- 15.2.2. Financial outlook
- 15.2.3. Product summary
- 15.2.4. Recent developments
15.3. Cordlife Group Limited
- 15.3.1. Company details
- 15.3.2. Financial outlook
- 15.3.3. Product summary
- 15.3.4. Recent developments
15.4. Cryo-Cell International Inc.
- 15.4.1. Company details
- 15.4.2. Financial outlook
- 15.4.3. Product summary
- 15.4.4. Recent developments
15.5. Cryoviva India
- 15.5.1. Company details
- 15.5.2. Financial outlook
- 15.5.3. Product summary
- 15.5.4. Recent developments
15.6. GBI
- 15.6.1. Company details
- 15.6.2. Financial outlook
- 15.6.3. Product summary
- 15.6.4. Recent developments
15.7. LifeCell International Pvt. Ltd.
- 15.7.1. Company details
- 15.7.2. Financial outlook
- 15.7.3. Product summary
- 15.7.4. Recent developments
15.8. Lonza
- 15.8.1. Company details
- 15.8.2. Financial outlook
- 15.8.3. Product summary
- 15.8.4. Recent developments
15.9. Merck KGaA
- 15.9.1. Company details
- 15.9.2. Financial outlook
- 15.9.3. Product summary
- 15.9.4. Recent developments
15.10. Reliance Life Sciences
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3. Product summary
- 15.10.4. Recent developments
15.11. SGS Life Sciences
- 15.11.1. Company details
- 15.11.2. Financial outlook
- 15.11.3. Product summary
- 15.11.4. Recent developments
15.12. Texcell
- 15.12.1. Company details
- 15.12.2. Financial outlook
- 15.12.3. Product summary
- 15.12.4. Recent developments
15.13. Wuxi Apptec
- 15.13.1. Company details
- 15.13.2. Financial outlook
- 15.13.3. Product summary
- 15.13.4. Recent developments
15.14. Others